Big Pharma is sticking to the recent molecular glue investment trend, with Pfizer now the latest major drugmaker to get in on ...
Pfizer is already active in the protein degrader area, having partnered with Arvinas in a $2 billion-plus deal signed in 2021 ...
Privately held Triana focuses on building a molecular glue pipeline developed through its platform, which is designed to identify small molecules that induce protein:protein interactions between ...
The next time you skip a workout or stay up late, consider this: your brain might still be feeling the effects two weeks from ...
Researchers from Aalto University and the University of Oulu in Finland tracked a neuroscientist’s brain and behavioral ...